Fibplant Israeli Company
Fibplant is developing a genetically engineered Fibrinogen, intended to be uses as a biological glue for an existing pharma drug market.
Health Tech & Life Sciences
Alternatives
No alternatives listed yet.
AI-Generated Alternatives
Powered by AI May contain mistakes
AI is thinking and generating alternatives...
Suggest an Alternative
References
[1]
finder.startupnationcentral.org
- https://finder.startupnationcentral.org/company_page/fibplant
External links are provided for reference and verification purposes.